Laura Nadeau is an Oncology physician affiliated with Beaumont Health. OpenAlex indexes 37 publications with 329 citations (h-index 8).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
3577 W 13 Mile Rd
Suite 103
Royal Oak, MI 480736710
Telephone
248-288-4500Provider last certified this registry record 19 Oct 2020.
Industry payments
74 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Gilead Sciences, Inc.Program year202513 payments
- Novartis Pharmaceuticals CorporationProgram year202521 payments
- Genentech USA, Inc.Program year20259 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Blood & clotting
57.2%Iron, parenteral preparations49.9%Ferric carboxymaltose100%Part B, office-administered≥26 patientsErythropoiesis-stimulating Agent7%Darbepoetin alfa78%Epoetin alfa22%Part B, office-administered≥15 patients+ 2 more classes in this area
Musculoskeletal
22.4%RANK Ligand Inhibitor22.1%Denosumab100%Part B, office-administered≥59 patientsBisphosphonate0.2%Zoledronic acid100%Part B, office-administered≥20 patients+ 1 more class in this area
Metabolism & gastrointestinal
11.4%Other antiemetics9.1%Fosaprepitant100%Part B, office-administered≥13 patientsSerotonin-3 Receptor Antagonist1.9%Palonosetron hcl82%Ondansetron hydrochloride16%Ondansetron Hcl2%Part D + Part B≥34 patients+ 5 more classes in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
Similar KOLs
Other experts from the same institution or the same specialty.
James Goldstein, MD
Beaumont Health
Pamela Marcovitz, MD
Beaumont Health
Donald Brabbins
Beaumont Health
Kathleen Dass, MD
Beaumont Health
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”